NICE received two appeals against the Final Evaluation Determination on the above HST evaluation from the following organisations:
• Aegerion Pharmaceuticals
• Lipodystrophy UK
The appeal panel will convene on Friday 30 August 2019 at NICE, 10 Spring Gardens, London, SW1A 2BU to hear oral representations from the appellants.